Delek US Stock Prediction and Forecast [DK]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 02 Oct 2025, 04:09 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for Delek US Stock Prediction and Forecast [DK]](https://i.ytimg.com/vi/RUfXFpI7MJc/hqdefault.jpg)
AI-generated source summary
The analysis examines Delek US (DK) stock, identifying its current classification as a 'Hold/Accumulate' with a score of 0.136 since August 22, 2025. Throughout this period, the stock has exceeded expectations, showing a gain of 32.73%, resulting in an average daily gain of 1.17%. It positions the stock within a broad upward trend in the short term, suggesting further increases. The current 3-month trend shows a potential change of approximately 43.76% over the next 3 months, with a possible return ranging from 17.17% to 51.61%. In terms of a longer outlook, our 12-month analysis indicates a projected change of about 44.97%. Based on our calculations, the stock's performance could vary between -25.74% and positive 50.67% over the coming year, leading to a potential future price between $24.12 and $48.94.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.